Compare National Perox. with Similar Stocks
Stock DNA
Commodity Chemicals
INR 340 Cr (Micro Cap)
30.00
42
0.00%
-0.16
3.21%
0.98
Total Returns (Price + Dividend) 
Latest dividend: 12.5 per share ex-dividend date: Aug-20-2024
Risk Adjusted Returns v/s 
Returns Beta
News

National Peroxide Ltd Upgraded to Buy on Improved Technicals and Attractive Valuation
National Peroxide Ltd has seen its investment rating upgraded from Hold to Buy, driven by a combination of improved technical indicators, attractive valuation metrics, and a positive financial trend. The micro-cap commodity chemicals company’s recent performance and outlook have prompted analysts to revise their assessment, reflecting growing investor confidence amid a challenging sector backdrop.
Read full news article
National Peroxide Ltd Valuation Shifts to Attractive Amid Strong Market Returns
National Peroxide Ltd, a micro-cap player in the commodity chemicals sector, has seen its valuation parameters shift from very attractive to attractive, reflecting evolving market perceptions and financial metrics. Despite a slight dip in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a nuanced change in price attractiveness relative to peers and historical benchmarks.
Read full news article
National Peroxide Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals
National Peroxide Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating downgraded from Buy to Hold as of 13 May 2026. This adjustment follows a reassessment of its technical indicators, despite the company’s robust financial performance and attractive valuation metrics. The downgrade reflects a nuanced view balancing strong earnings growth against emerging technical headwinds.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-May-2026 | Source : BSEPlease find attached clipping of Newspaper Publication.
Board Meeting Outcome for Outcome Of Board Meeting
30-Apr-2026 | Source : BSEThis is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e. on April 30 2026 had inter-alia considered and approved the following items of business: 1. Statement of Audited Financial Results for the quarter and financial year ended March 31 2026 2. Recommendation of the Dividend 3. Change in Key Managerial Personnel of the Company:
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
30-Apr-2026 | Source : BSEThe Company hereby informs the Exchange that Mr. Amit Goriwale has step down from the position of Interim Chief Financial Officer of the Company from close of business hours May 31 2026
Corporate Actions 
No Upcoming Board Meetings
National Peroxide Ltd has declared 125% dividend, ex-date: 20 Aug 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Nowrosjee Wadia And Sons Limited (33.08%)
None
24.95%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 24.01% vs 1.17% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 333.33% vs 369.23% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -10.64% vs -6.39% in Sep 2024
Growth in half year ended Sep 2025 is -77.78% vs -35.64% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -4.29% vs -12.97% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -26.65% vs -69.10% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.99% vs -13.85% in Mar 2025
YoY Growth in year ended Mar 2026 is 590.67% vs -113.40% in Mar 2025






